COMT

COMT

Target · Methyltransferase enzyme

COMT Catechol-O-methyltransferase · Catechol O-methyltransferase

COMT (catechol-O-methyltransferase) is an enzyme that catalyses the O-methylation, and thereby the inactivation, of catecholamine neurotransmitters and catechol hormones. It also shortens the biological half-lives of certain neuroactive drugs. Browse Assay Genie's current range of COMT research reagents below, or read on for the biology behind the target.

Cytoplasm and cell membraneSAM-dependent methyltransferaseSoluble and membrane-bound forms
271 aa
Protein length
~30 kDa
Molecular weight
22q11.21
Gene locus
EC 2.1.1.6
Enzyme class
Target information

What is COMT (catechol-O-methyltransferase)?

COMT transfers a methyl group from S-adenosylmethionine to catecholamines, including the neurotransmitters dopamine, epinephrine and norepinephrine. This O-methylation is one of the major degradative pathways of the catecholamine transmitters. The enzyme also acts on catechol hormones, and it shortens the biological half-lives of certain neuroactive drugs such as L-DOPA, alpha-methyl DOPA and isoproterenol.

The COMT protein belongs to the class I-like SAM-binding methyltransferase superfamily and the cation-dependent O-methyltransferase family. In HGNC the COMT gene sits in the groups of small molecule methyltransferases and of microRNA protein coding host genes. UniProt records the protein in the cytoplasm and at the cell membrane, which fits the two forms found in tissues: a soluble form (S-COMT) and a membrane-bound form (MB-COMT). The two forms differ in their N-termini, and several transcript variants arise through alternative translation initiation sites and promoters.

Beyond its role in metabolising endogenous substances, COMT is important in the metabolism of catechol drugs used in the treatment of hypertension, asthma and Parkinson disease. This makes it a common subject in neurochemistry and pharmacology. Mouse and rat both carry a Comt ortholog, so the enzyme can be studied in standard rodent models.

Catecholamine metabolism

COMT O-methylation is one of the major degradative pathways for dopamine, epinephrine and norepinephrine, so it is central to studies of catecholamine inactivation.

Neuropharmacology

The enzyme shortens the half-lives of neuroactive drugs including L-DOPA, alpha-methyl DOPA and isoproterenol, which makes it relevant to drug metabolism research.

Parkinson disease research

COMT contributes to the metabolism of catechol drugs used to treat Parkinson disease, hypertension and asthma.

Isoform and variant studies

Soluble S-COMT and membrane-bound MB-COMT differ at the N-terminus and arise from alternative promoters and translation start sites.

Background

COMT frequently asked questions

What does COMT do?

COMT catalyses the transfer of a methyl group from S-adenosylmethionine to catecholamines such as dopamine, epinephrine and norepinephrine. This O-methylation inactivates catecholamine neurotransmitters and catechol hormones, and it also shortens the half-lives of drugs such as L-DOPA.

What are S-COMT and MB-COMT?

COMT occurs in tissues as a soluble form (S-COMT) and a membrane-bound form (MB-COMT). They differ in their N-termini. Several transcript variants are produced through alternative translation initiation sites and promoters, which fits the cytoplasmic and cell membrane localisation recorded in UniProt.

Is COMT conserved in mouse and rat?

Yes. Mouse and rat each have an ortholog named Comt, so the enzyme can be studied in rodent models. Human COMT is linked to the metabolism of drugs used in hypertension, asthma and Parkinson disease. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other methyltransferases and catecholamine-pathway targets with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P21964; product specifications from Assay Genie datasheets.

COMT Product listing